Lenalidomide plus rituximab achieves 87% response rateNovember 4, 2015Lymphoma & Plasma Cell DisordersMelanoma
Nonmelanoma skin cancer initially misdiagnosed in 36% of small cohortOctober 20, 2015MelanomaPediatricsNonmelanoma Skin Cancer
New systemic therapies altering management of melanoma brain metastasesOctober 19, 2015MelanomaNeuro-oncology
EADV: Prophylactic photodynamic therapy benefits transplant recipientsOctober 18, 2015MelanomaNonmelanoma Skin Cancer